Functional communication between endogenous BRCA1 and its partner, BARD1, during Xenopus laevis development

被引:126
作者
Joukov, V
Chen, J
Fox, EA
Green, JBA
Livingston, DM
机构
[1] Dana Farber Canc Inst, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, Boston, MA 02115 USA
关键词
D O I
10.1073/pnas.211427098
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The breast and ovarian susceptibility protein 1 (BRCA1) heterodimerizes with its structural relative, the BRCA1-associated RING domain protein (BARD1), which may have tumor suppressing function in its own right. Both proteins have evolved from a common evolutionary ancestor, and both exist in Xenopus laevis where, similar to their mammalian homologs, they form functional heterodimers. Depleting frog embryos of either BARD1 or BRCA1 led to similar and widely defective developmental phenotypes as well as depletion of the other polypeptide due to its decreased stability, Thus, each protein, in part, controls the abundance, stability, and function of the other, and these effects are heterodimerization-dependent. The interdependent nature of BRCA1 and BARD1 function supports the view that BARD1/BRCA1 heterodimers play a major role in breast and ovarian cancer suppression.
引用
收藏
页码:12078 / 12083
页数:6
相关论文
共 38 条
  • [1] BACH1, a novel helicase-like protein, interacts directly with BRCA1 and contributes to its DNA repair function
    Cantor, SB
    Bell, DW
    Ganesan, S
    Kass, EM
    Drapkin, R
    Grossman, S
    Wahrer, DCR
    Sgroi, DC
    Lane, WS
    Haber, DA
    Livingston, DM
    [J]. CELL, 2001, 105 (01) : 149 - 160
  • [2] Stable interaction between the products of the BRCA1 and BRCA2 tumor suppressor genes in mitotic and meiotic cells
    Chen, JJ
    Silver, DP
    Walpita, D
    Cantor, SB
    Gazdar, AF
    Tomlinson, G
    Couch, FJ
    Weber, BL
    Ashley, T
    Livingston, DM
    Scully, R
    [J]. MOLECULAR CELL, 1998, 2 (03) : 317 - 328
  • [3] COOKE J, 1979, J EMBRYOL EXP MORPH, V51, P165
  • [4] ISOLATION OF MONOCLONAL-ANTIBODIES SPECIFIC FOR HUMAN C-MYC PROTO-ONCOGENE PRODUCT
    EVAN, GI
    LEWIS, GK
    RAMSAY, G
    BISHOP, JM
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 1985, 5 (12) : 3610 - 3616
  • [5] Brca1 deficiency results in early embryonic lethality characterized by neuroepithelial abnormalities
    Gowen, LC
    Johnson, BL
    Latour, AM
    Sulik, KK
    Koller, BH
    [J]. NATURE GENETICS, 1996, 12 (02) : 191 - 194
  • [6] RETRACTED: BRCA1 required for transcription-coupled repair of oxidative DNA damage (Retracted article. See vol 300, pg 1657, June 13 2003)
    Gowen, LC
    Avrutskaya, AV
    Latour, AM
    Koller, BH
    Leadon, SA
    [J]. SCIENCE, 1998, 281 (5379) : 1009 - 1012
  • [7] GRAF JD, 1991, METHOD CELL BIOL, V36, P19
  • [8] The tumor suppressor gene Brca1 is required for embryonic cellular proliferation in the mouse
    Hakem, R
    delaPompa, JL
    Sirard, C
    Mo, R
    Woo, M
    Hakem, A
    Wakeham, A
    Potter, J
    Reitmair, A
    Billia, F
    Firpo, E
    Hui, CC
    Roberts, J
    Rossant, J
    Mak, TW
    [J]. CELL, 1996, 85 (07) : 1009 - 1023
  • [9] The RING heterodimer BRCA1-BARD1 is a ubiquitin ligase inactivated by a breast cancer-derived mutation
    Hashizume, R
    Fukuda, M
    Maeda, I
    Nishikawa, H
    Oyake, D
    Yabuki, Y
    Ogata, F
    Ohta, T
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (18) : 14537 - 14540
  • [10] β-catenin signaling activity dissected in the early Xenopus embryo:: A novel antisense approach
    Heasman, J
    Kofron, M
    Wylie, C
    [J]. DEVELOPMENTAL BIOLOGY, 2000, 222 (01) : 124 - 134